Global Meningococcal vaccines market - 2013 - 2019

Transparency Market Research Meningococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Published Date 28-April-2014

109 Page Report

Buy Now

Request Sample

Press Release Global Meningococcal Vaccines Market to be Worth US$3.7 billion by 2019: Transparency Market Research Transparency Market Research State Tower, 90, State Street, Suite 700.

Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com

Meningococcal Vaccines Market

REPORT DESCRIPTION

Meningococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Transparency Market Research, a U.S. based market intelligence firm has added the report, titled “Meningococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019�, to its research reports repository. The report states that the global meningococcal vaccines market has the potential of growing at a CAGR of 14.9% during 2013 and 2019. Growing at this pace, this market that valued US$1.5 billion in 2012 could achieve a net worth of US$3.7 billion by 2019.

Browse the full report at http://www.transparencymarketresearch.com/meningococcal-vaccines-market.html Various strains of meningococcal bacteria cause serious infection to the thin lining surrounding the brain and spinal cord. The infection results in severe brain damage and can be fatal in 50% cases if left untreated. The high fatality rate of meningococcal disease is generally considered as a medical emergency.

This is why, federal governments of various countries are actively involved in efforts for spreading awareness about the severity of the condition. Many government bodies are also involved in the research, development, and also the distribution of meningococcal vaccines regionally.

Transparency Market Research’s report on the global meningococcal vaccines market presents an allinclusive overview of the market and its various segments.

The report mainly focuses on major market segments based on the types of vaccines available in the meningococcal vaccine market, such as Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines, and the vaccines in pipeline. The product types are further segmented according to the brands that feature them. An overview of geographically specific active regional markets is also included in the report.

Conjugates are expected to lead the global meningococcal vaccines market in the future. By observing growth at a CAGR of 12.9%, this product segment could amass net worth of nearly US$2.5 billion by 2019.

Transparency Market Research

2

Meningococcal Vaccines Market

Amongst the various meningococcal vaccines in pipeline currently, Novartis’s Bexsero is expected to gain market shares at the fastest pace, an expected 24.7%, during the forecast period.

We are currently offering a flat 15% discount on all purchases until end of the March 2015! http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1666 The Department of Health, UK, states that Baxsero will be the first vaccine for serogroup B in the meningococcal vaccines market after its launch in the second quarter of 2014. Pfizer’s MnB rLP2086 is another potential future vaccine that is currently in its third phase of trial. The launch of this vaccine, which has received a Breakthrough Therapy status from the U.S. FDA, is expected to change the complete outlook of this market by intensifying competition.

Geographically, North America was the leading shareholder of the global meningococcal vaccines market in 2011 due to government led immunization programs and favorable research and development initiatives undertaken by major drug companies in this region. Also, every year nearly 1,000 to 2,600 people in the U.S. contract meningitis from various strains of the bacteria. However, vaccines for only the serotypes A, C, Y, and W-135 are available in the U.S. market.

Regional market of Asia Pacific is expected to grow at the fastest pace in the global meningococcal vaccines market, at an estimated CAGR of 17.1%, by the end of 2019. Major drivers of growth in these regional markets are the low manufacturing cost of vaccines, and transfer of novel manufacturing technologies from developed countries to these regions.

The global meningococcal vaccines market is segmented as follow: Meningococcal Vaccines Market, by Type •Polysaccharide Vaccines, by Brand •Menomune •Mencevax •NmVac4 •Others

Transparency Market Research

3

Meningococcal Vaccines Market

•Quadri Meningo •Bi Meningo •Conjugate Vaccines, by Brand •Menactra •Menveo •NeisVac-C •Nimenrix •Meningitec •Menjugate •MenAfriVac •Combination Vaccines, by Brand •MenHibrix •Menitorix •Pipeline Vaccines, by Brand •Bexsero •MnB rLP2806 •NmVac4-DT Meningococcal Vaccines Market, by Geography • North America • Europe • Asia-Pacific

Transparency Market Research

4

Meningococcal Vaccines Market

• Rest of the World

Browse More Report on Pharmaceuticals Market: http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

TABLE OF CONTENT

Chapter 1 Introduction 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.3.1 Secondary Research 1.3.2 Primary Research 1.4 List of Abbreviations 1.5 Assumptions

Chapter 2 Executive Summary 2.1 Market Snapshot: Global Meningococcal Vaccines Market 2.2 Global Meningococcal Vaccines Market Revenue, 2011 – 2019 (USD Million) 2.3 Comparative Analysis: Global Meningococcal Vaccines Market, by Geography, 2012 & 2019 (Value %)

Chapter 3 Global Meningococcal Vaccines Market Overview 3.1 Introduction 3.1.1 Meningococcal Disease 3.1.1.1 Clinical Features

Transparency Market Research

5

Meningococcal Vaccines Market

3.1.1.2 Epidemiology 3.1.1.3 Diagnosis & Treatment 3.1.2 Types of Meningococcal Vaccines 3.2 Regulatory Scenario 3.3 Market Drivers 3.3.1 Developing economies reshaping global health and development 3.3.2 Education and awareness through various non-profit organizations 3.3.3 Travel vaccines for meningococcal disease 3.4 Market Restraints 3.4.1 Disparate age groups and dosage regimen for routine immunization, and unpredictable and dynamic epidemiology of meningococcal disease 3.4.2 Maintenance of cold chains to deliver vaccines leading to high cost of vaccination 3.5 Market Opportunities 3.5.1 Development of vaccines through collaborations and public private partnerships making vaccines more affordable 3.5.2 Novel approaches to improve the stability of meningococcal vaccines 3.5.3 Developing halal vaccines 3.6 Porter’s Five Force Analysis for the Global Meningococcal Vaccines Market 3.6.1 Bargaining Power of Suppliers 3.6.2 Bargaining Power of Buyers 3.6.3 Threat of Substitutes 3.6.4 Threat of New Entrants 3.6.5 Competitive Rivalry 3.7 Market Attractiveness Analysis for the Global Meningococcal Vaccines Market, by Geography

Transparency Market Research

6

Meningococcal Vaccines Market

Chapter 4 Global Meningococcal Vaccines Market, by Type 4.1 Introduction 4.1.1 Global Meningococcal Vaccines Market Revenue, by Type, 2011 - 2019 (USD Million) 4.2 Comparative Analysis: Global Meningococcal Vaccines Market, by Type, 2012 & 2018 (Value %) 4.3 Polysaccharide Meningococcal Vaccines 4.3.1 Global Polysaccharide Vaccines Market Revenue, by Brand, 2011 - 2019 (USD Million) 4.3.2 Menomune 4.3.2.1 Global Menomune Market Revenue, 2011 - 2019 (USD Million) 4.3.3 Mencevax 4.3.3.1 Global Mencevax Market Revenue, 2011 – 2014 (USD Million) 4.3.4 NmVac4-A/C/Y/W-135 4.3.4.1 Global NmVac4 Market Revenue, 2011 – 2015 (USD Million) 4.3.5 Others (Bi Meningo, Quadri Meningo) 4.3.5.1 Global Other Polysaccharide Vaccines Market Revenue, 2011 – 2019 (USD Million) 4.4 Conjugate Meningococcal Vaccines 4.4.1 Global Conjugate Vaccines Market Revenue, by Brand, 2011 - 2019 4.4.2 Menactra 4.4.2.1 Global Menactra Market Revenue, 2011 - 2019 (USD Million) 4.4.3 Menveo 4.4.3.1 Global Menveo Market Revenue, 2011 - 2019 (USD Million) 4.4.4 NeisVac-C 4.4.4.1 Global NeisVac-C Market Revenue, 2011 - 2019 (USD Million) 4.4.5 Nimenrix 4.4.5.1 Global Nimenrix Market Revenue, 2012 - 2019 (USD Million)

Transparency Market Research

7

Meningococcal Vaccines Market

4.4.6 Meningitec 4.4.6.1 Global Meningitec Market Revenue, 2011 - 2019 (USD Million) 4.4.7 Menjugate (Meningococcal Group C- CRM197 Conjugate Vaccine) 4.4.7.1 Global Menjugate Market Revenue, 2011 - 2019 (USD Million) 4.4.8 MenAfriVac 4.4.8.1 Global MenAfriVac Market Revenue, 2011 - 2019 (USD Million) 4.5 Combination Meningococcal Vaccines 4.5.1 Global Combination Vaccines Market Revenue, by Brand, 2011 - 2019 (USD Million) 4.5.2 MenHibrix 4.5.2.1 Global MenHibrix Market Revenue, 2013 - 2019 (USD Million) 4.5.3 Menitorix 4.5.3.1 Global Menitorix Market Revenue, 2011 - 2019 (USD Million) 4.6 Pipeline Analysis 4.6.1 Global Meningococcal Vaccines Market Pipeline Forecast, by Brand, 2011 - 2019 (USD Million) 4.6.2 Bexsero 4.6.2.1 Global Bexsero Market Revenue, 2013 - 2019 (USD Million) 4.6.3 MnB rLP2806 4.6.3.1 Global MnB rLP2806 Market Revenue, 2017 - 2019 (USD Million) 4.6.4 NmVac4-A/C/Y/W-135-DT 4.6.4.1 Global NmVac4 DT Market Revenue, 2015 - 2019 (USD Million)

Chapter 5 Global Meningococcal Vaccines Market, by Geography 5.1 Introduction 5.1.1 Global Meningococcal Vaccines Market Revenue, by Geography, 2011 - 2019 (USD Million)

Transparency Market Research

8

Meningococcal Vaccines Market

5.2 North America 5.2.1 North America Meningococcal Vaccines Market Revenue, 2011 – 2019 (USD Million) 5.3 Europe 5.3.1 Europe Meningococcal Vaccines Market Revenue, 2011 – 2019 (USD Million) 5.4 Asia-Pacific 5.4.1 Asia-Pacific Meningococcal Vaccines Market Revenue, 2011 – 2019 (USD Million) 5.5 Rest of the World 5.5.1 Rest of the World Meningococcal Vaccines Market Revenue, 2011 – 2019 (USD Million)

Chapter 6 Competitive Landscape 6.1 Market Share by Key Players, 2012 (Value %) 6.1.1 Methodology 6.1.2 Analysis

Chapter 7 Recommendations 7.1 Focus on Low Cost of Manufacturing 7.2 Developing Animal Component Free and Halal Vaccines 7.3 Tapping Emerging Markets 7.4 Collaborating With Community Pharmacies

Chapter 8 Company Profiles 8.1 Baxter International, Inc. 8.1.1 Company Overview 8.1.2 Financial Overview

Transparency Market Research

9

Meningococcal Vaccines Market

8.1.3 Product Portfolio 8.1.4 Business Strategies 8.1.5 Recent Developments 8.2 Biomed Pvt. Ltd. 8.2.1 Company Overview 8.2.2 Financial Overview 8.2.3 Product Portfolio 8.2.4 Business Strategies 8.2.5 Recent Developments 8.3 GlaxoSmithKline plc 8.3.1 Company Overview 8.3.2 Financial Overview 8.3.3 Product Portfolio 8.3.4 Business Strategies 8.3.5 Recent Developments 8.4 JN-International Medical Corporation 8.4.1 Company Overview 8.4.2 Financial Overview 8.4.3 Product Portfolio 8.4.4 Business Strategies 8.4.5 Recent Developments 8.5 Novartis International AG 8.5.1 Company Overview 8.5.2 Financial Overview

Transparency Market Research

10

Meningococcal Vaccines Market

8.5.3 Product Portfolio 8.5.4 Business Strategies 8.5.5 Recent Developments 8.6 Nuron Biotech, Inc. 8.6.1 Company Overview 8.6.2 Financial Overview 8.6.3 Product Portfolio 8.6.4 Business Strategies 8.6.5 Recent Developments 8.7 Pfizer, Inc. 8.7.1 Company Overview 8.7.2 Financial Overview 8.7.3 Product Portfolio 8.7.4 Business Strategies 8.7.5 Recent Developments 8.8 Sanofi SA 8.8.1 Company Overview 8.8.2 Financial Overview 8.8.3 Product Portfolio 8.8.4 Business Strategies 8.8.5 Recent Developments 8.9 Serum Institute of India Ltd. 8.9.1 Company Overview 8.9.2 Financial Overview

Transparency Market Research

11

Meningococcal Vaccines Market

8.9.3 Product Portfolio 8.9.4 Business Strategies 8.9.5 Recent Developments

Browse Full Press Release @ http://www.transparencymarketresearch.com/pressrelease/meningococcal-vaccinesmarket.htm

About Us Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers.

Contact

Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/ Browse The Market Research Blog : https://marketsresearchindustry.wordpress.com/

Transparency Market Research

12